LINQ II Insertable Cardiac Monitor vs Withings Scan Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Withings

AI Verdict

The Medtronic LINQ II is an implantable cardiac monitor providing long-term, continuous, and diagnostic-grade arrhythmia detection for clinical diagnosis. In contrast, the Withings Scan Monitor offers non-invasive, device-based cardiac monitoring (ECG for AFib, heart rate) alongside other vital health metrics, primarily for personal health management and less intensive remote patient monitoring. While both leverage AI for cardiac health, their distinct deployment methods and target use cases make them adjacent rather than direct competitors.

Choose LINQ II Insertable Cardiac Monitor if…

Choose the Medtronic LINQ II if you require long-term, highly accurate, and continuous diagnostic monitoring for complex or infrequent cardiac arrhythmias, particularly when external monitoring has been inconclusive. This insertable cardiac monitor is ideal for patients needing extended surveillance, including pediatric cases, where definitive diagnosis and remote management of significant rhythm disturbances are critical.

View LINQ II Insertable Cardiac Monitor →

Choose Withings Scan Monitor if…

Choose the Withings Scan Monitor if you are seeking a non-invasive, integrated solution for proactive personal health management or remote patient monitoring that combines cardiac rhythm screening with other vital health metrics. This tool is well-suited for individuals and clinicians focused on early AFib detection, tracking general cardiovascular health, and monitoring overall wellness through smart scales and smartwatches.

View Withings Scan Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature LINQ II Insertable Cardiac Monitor Withings Scan Monitor
Pricing Unknown Device purchase with optional subscription for enhanced features and clinical services.
Deployment Subcutaneous implant with remote monitoring via mobile app or home communicator. Device-based (smart scale, smartwatch) with cloud synchronization and mobile application.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

LINQ II Insertable Cardiac Monitor

Once implanted, the LINQ II offers a largely passive monitoring experience for the patient, with automatic data transmission and remote programming for clinicians. This reduces the daily burden on the patient compared to actively using a smart scale or smartwatch for measurements.

Clinical Value

LINQ II Insertable Cardiac Monitor

The LINQ II provides continuous, long-term (up to 4.5 years), and highly specialized monitoring for diagnosing intermittent and often elusive cardiac arrhythmias, which is critical for patient management. While Tool B offers valuable health metrics, its monitoring is episodic or daily, not continuous over years, making Tool A superior for definitive arrhythmia diagnosis.

Pricing & Value

Withings Scan Monitor

Withings offers transparent, consumer-friendly pricing for its devices and optional subscription services, making it accessible for individual users and smaller-scale remote patient monitoring programs. In contrast, Medtronic's enterprise pricing for the LINQ II is not publicly disclosed, making its value proposition less transparent for a broader audience, despite its specialized clinical value.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Medtronic's LINQ II is clearly designed and established for enterprise healthcare environments, evidenced by its vast installed base of over 1 million patients and features tailored for integration into clinical workflows. While Withings supports professional RPM, its foundation is in consumer devices, making Tool A more robustly 'enterprise ready'.

Innovation

Tie

Both tools demonstrate significant innovation in their respective domains. LINQ II pushes the boundaries of implantable cardiac monitoring with advanced AI algorithms and remote management, while Withings innovates by democratizing sophisticated health diagnostics through consumer-friendly wearables and smart devices like a 6-lead ECG in a smart scale.

Support & Docs

LINQ II Insertable Cardiac Monitor

Medtronic provides dedicated phone lines for both patient services and technical support, available during business hours, which is critical for an implantable medical device. Withings primarily relies on online and chat support, with a general customer service phone number not readily available, which may be less immediate for complex medical device inquiries.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature LINQ II Insertable Cardiac Monitor Withings Scan Monitor
Product Name LINQ II Insertable Cardiac Monitor Withings Scan Monitor
Company Medtronic Withings
ECG/AFib Detection Long-term, continuous heart rhythm monitoring for diagnosing arrhythmias 6-lead ECG for Atrial Fibrillation (AFib) detection (Body Scan); Single-lead ECG for Atrial Fibrillation (AFib) detection (ScanWatch)
Other Key Monitoring Capabilities Not specified Heart rate measurement and irregular rhythm notifications, Blood oxygen saturation (SpO2) measurement (ScanWatch), Vascular Age assessment (Body Scan), Nerve Health Score (Electrodermal Activity) (Body Scan), Segmental body composition analysis (Body Scan)
AI Algorithms AccuRhythmu2122 AI algorithms for enhanced accuracy, Innovative PVC detection algorithm AI-powered tool
Continuous Monitoring Duration Up to 4.5 years of continuous monitoring Not specified

Videos

Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and Withings Scan Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Medtronic LINQ II is an insertable cardiac monitor providing long-term, continuous heart rhythm monitoring for up to 4.5 years, primarily focused on diagnosing arrhythmias. In contrast, the Withings Scan Monitor is an AI-powered tool integrated into smart scales and smartwatches, offering intermittent ECG for AFib detection, heart rate, and other vital health metrics for both personal use and professional remote patient monitoring.
The Medtronic LINQ II is designed for diagnosing arrhythmias and includes an innovative PVC detection algorithm. The Withings Scan Monitor primarily focuses on Atrial Fibrillation (AFib) detection via 6-lead ECG on the Body Scan and single-lead ECG on the ScanWatch, along with irregular rhythm notifications.
The Medtronic LINQ II utilizes AccuRhythmu2122 AI algorithms for enhanced accuracy in detecting and diagnosing arrhythmias, which have been shown to reduce false alerts for AFib and pause. The Withings Scan Monitor is an AI-powered tool that integrates into its devices to provide FDA-cleared ECG for AFib detection and other health metrics.
The Medtronic LINQ II features remote programming capability for all device parameters post-insertion, which may reduce patient office visits. The Withings Scan Monitor focuses on automatic data synchronization via its mobile application and cloud for remote patient monitoring, but does not explicitly mention remote programming of the device itself.
The Medtronic LINQ II is specialized for long-term continuous cardiac rhythm monitoring, including arrhythmia and PVC detection. The Withings Scan Monitor, particularly the Body Scan, offers a broader range of metrics including 6-lead ECG for AFib, heart rate, vascular age assessment, nerve health score, and segmental body composition analysis, while the ScanWatch also measures blood oxygen saturation (SpO2).
AI Tool Finder
AI-powered search. Results may not be comprehensive.